This pancreatic cancer drug may extend lives — if patients can afford it

This pancreatic cancer drug may extend lives — if patients can afford it

Vancouver's James Howard is paying $90,000 a month for a new pancreatic cancer treatment that may add a few more months to his life. But, he's far from the only Canadian who is faced with having to find the means to access new cancer medicines at high costs and it's an issue that front-line oncologists across the country say is pushing public health care past a breaking point.